Suppr超能文献

机械心脏瓣膜与妊娠:抗凝相关问题。来自两个产科心脏中心的经验。

Mechanical heart valves and pregnancy: Issues surrounding anticoagulation. Experience from two obstetric cardiac centres.

作者信息

Dos Santos Francois, Baris Lucia, Varley Alice, Cornette Jerome, Allam Joanna, Steer Philip, Swan Lorna, Gatzoulis Michael, Roos-Hesselink Jolien, Johnson Mark R

机构信息

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Obstet Med. 2021 Jun;14(2):95-101. doi: 10.1177/1753495X20924937. Epub 2020 Jun 2.

Abstract

BACKGROUND

Pregnant women with mechanical heart valves are at significant risk of obstetric/cardiac complications. This study compares the anticoagulation management in two obstetric cardiac centres.

METHODS

Retrospective case-note review from Chelsea and Westminster/Royal Brompton Hospitals (CR) and Erasmus Medical Centre (EMC). Main outcome measure was mechanical heart valve thrombosis.

RESULTS

Nineteen pregnancies from CR and 25 pregnancies from EMC were included. Most women were on low-molecular-weight heparin (LMWH) throughout pregnancy at CR, whereas at EMC most had LMWH in the first trimester and vitamin K antagonists in subsequent trimesters. Peak anti-factor Xa were performed monthly at CR, levels 0.39-1.51 IU/mL (mean 0.82 IU/mL). Anticoagulation management peri-partum was inconsistent. Delivery was mainly by caesarean section at CR (74%) and vaginal delivery at EMC (64%). No maternal deaths and only one mechanical heart valve thrombosis at CR. Two mechanical heart valve thromboses and one maternal death at EMC.

CONCLUSION

Peri-partum anticoagulation strategies, anticoagulation monitoring and mode of delivery inconsistencies reported.

摘要

背景

患有机械心脏瓣膜的孕妇面临产科/心脏并发症的重大风险。本研究比较了两个产科心脏中心的抗凝管理情况。

方法

对切尔西和威斯敏斯特医院/皇家布朗普顿医院(CR)以及伊拉斯谟医疗中心(EMC)进行回顾性病例记录审查。主要结局指标是机械心脏瓣膜血栓形成。

结果

纳入了CR的19例妊娠和EMC的25例妊娠。在CR,大多数女性在整个孕期都使用低分子量肝素(LMWH),而在EMC,大多数女性在孕早期使用LMWH,在随后的孕期使用维生素K拮抗剂。在CR每月进行抗Xa因子峰值检测,水平为0.39 - 1.51 IU/mL(平均0.82 IU/mL)。围产期抗凝管理不一致。在CR,分娩主要通过剖宫产(74%),在EMC主要通过阴道分娩(64%)。CR没有孕产妇死亡,只有1例机械心脏瓣膜血栓形成。EMC有2例机械心脏瓣膜血栓形成和1例孕产妇死亡。

结论

报告了围产期抗凝策略、抗凝监测和分娩方式的不一致情况。

相似文献

1
Mechanical heart valves and pregnancy: Issues surrounding anticoagulation. Experience from two obstetric cardiac centres.
Obstet Med. 2021 Jun;14(2):95-101. doi: 10.1177/1753495X20924937. Epub 2020 Jun 2.
2
Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review.
Medicine (Baltimore). 2022 Dec 30;101(52):e32550. doi: 10.1097/MD.0000000000032550.
3
Use of low molecular weight heparin in pregnant women with mechanical heart valves.
Am J Cardiol. 2009 Nov 1;104(9):1259-63. doi: 10.1016/j.amjcard.2009.06.040. Epub 2009 Sep 16.
4
Biological versus mechanical heart valve prosthesis during pregnancy in women with congenital heart disease.
Int J Cardiol. 2018 Oct 1;268:106-112. doi: 10.1016/j.ijcard.2018.05.038. Epub 2018 May 23.
6
Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.
Arch Gynecol Obstet. 2016 Jan;293(1):69-74. doi: 10.1007/s00404-015-3768-0. Epub 2015 Jun 6.
7
Mechanical heart valve thrombosis during pregnancy under nonwarfarin anticoagulation therapy: Twocase report and literature review.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Feb 28;46(2):207-211. doi: 10.11817/j.issn.1672-7347.2021.200645.
8
Monitoring of anti-Xa in pregnant patients with mechanical prosthetic valves receiving low-molecular-weight heparin: peak or trough levels?
J Cardiovasc Pharmacol Ther. 2014 Sep;19(5):451-6. doi: 10.1177/1074248414524302. Epub 2014 Mar 6.

引用本文的文献

1
Mechanical heart valves and pregnancy.
JRSM Cardiovasc Dis. 2025 Aug 6;14:20480040251365987. doi: 10.1177/20480040251365987. eCollection 2025 Jan-Dec.
2
Strategies for low-molecular-weight heparin management in pregnant women with mechanical prosthetic heart valves: A nationwide survey of Dutch practice.
Int J Cardiol Congenit Heart Dis. 2022 Apr 12;9:100373. doi: 10.1016/j.ijcchd.2022.100373. eCollection 2022 Sep.

本文引用的文献

1
Postpartum anticoagulation in women with mechanical heart valves.
Int J Womens Health. 2018 Oct 25;10:663-670. doi: 10.2147/IJWH.S177547. eCollection 2018.
2
State of the Art Management of Mechanical Heart Valves During Pregnancy.
Curr Treat Options Cardiovasc Med. 2018 Nov 12;20(12):102. doi: 10.1007/s11936-018-0702-3.
3
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.
Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.
4
Anti-Xa based dose changes during low molecular weight heparin anticoagulation for mechanical prosthetic heart valves during pregnancy.
J Obstet Gynaecol. 2018 Jul;38(5):721-722. doi: 10.1080/01443615.2017.1387521. Epub 2018 Feb 13.
5
2017 ESC/EACTS Guidelines for the management of valvular heart disease.
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
6
Anticoagulation Therapy for Pregnant Women With Mechanical Prosthetic Heart Valves: How to Improve Safety?
J Am Coll Cardiol. 2017 Jun 6;69(22):2692-2695. doi: 10.1016/j.jacc.2017.04.034.
7
Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves.
J Am Coll Cardiol. 2017 Jun 6;69(22):2681-2691. doi: 10.1016/j.jacc.2017.03.605.
8
Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis.
Eur Heart J. 2017 May 14;38(19):1509-1516. doi: 10.1093/eurheartj/ehx032.
9
Anticoagulant options in pregnancy for women with mechanical valves.
BJOG. 2017 Aug;124(9):1421. doi: 10.1111/1471-0528.14517. Epub 2017 Feb 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验